新辅助化疗后腋窝淋巴结残留孤立肿瘤细胞或微转移的乳腺癌患者区域淋巴结放疗
本研究基于美国国家癌症数据库(NCDB)2004至2016年数据,纳入1980例接受新辅助化疗及根治性手术、术后病理为ypN0i+或ypN1mi的cN1浸润性乳腺癌患者,评估区域淋巴结放疗(RNI)对总生存(OS)的影响。多因素Cox回归、Kaplan-Meier法及IPTW加权分析均显示RNI对OS无显著影响,ypN0i+与ypN1mi两组OS无显著差异。
要点
- cN1乳腺癌新辅助化疗后残留ITC或微转移者,RNI对OS无显著影响。
- ypN0i+与ypN1mi两组患者OS无显著差异。
- IPTW加权分析结果与Cox多因素及KM分析一致。
核心结论
- 在cN1浸润性乳腺癌新辅助化疗后残留ITC或微转移的患者中,RNI对OS无显著影响。
研究设计与样本
- 基于美国国家癌症数据库(NCDB)的回顾性队列研究,纳入2004至2016年诊断为cN1浸润性乳腺癌、接受新辅助化疗及根治性手术、术后病理为ypN1mi或ypN0i+的患者,最终队列1980例。
主要发现
- 最终队列1980例,其中ypN0i+ 527例,ypN1mi 1453例。
- 总体队列中1101例(45.0%)接受RNI,ypN1mi患者接受RNI比例(56.5%)高于ypN0i+患者(53.1%)。
- ypN0i+与ypN1mi患者OS无显著差异。
- Cox多因素分析和KM法显示RNI对总体队列OS无显著影响。
- ypN0i+和ypN1mi亚组分别分析,RNI对OS均无显著影响,IPTW分析证实该结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/PURPOSE: The optimal management of residual micrometastases and isolated tumor cells (ITC) in patients with invasive breast cancer who undergo neoadjuvant chemotherapy (NAC) followed by definitive surgery is not well-studied. We evaluated the role of regional nodal irradiation (RNI) in clinically node-positive (cN1) breast cancer patients with residual low-volume nodal disease following NAC. METHODS/MATERIALS: We queried the National Cancer Database (NCDB) and included patients with cN1 invasive breast cancer diagnosed from 2004 to 2016 who were treated with NAC and definitive surgery and had residual micrometastases (ypN1mi) or ITC (ypN0i+). We used univariable (UVA) and multivariable (MVA) Cox regression analyses to determine prognostic factors and Kaplan-Meier (KM) methods to evaluate overall survival (OS). We used inverse probability treatment weighting (IPTW) to reweight data to account for confounding factors. RESULTS: Our final cohort included 1980 patients, including 527 patients with ypN0i + disease and 1453 patients with ypN1mi disease. 1101 patients (45.0%) received RNI in the overall cohort with a higher proportion of ypN1mi patients receiving RNI (56.5%) compared to 53.1% of ypN0i + patients. There was no significant difference in OS between ypN0i + and ypN1mi patients. RNI had no significant effect on OS in the overall cohort using Cox MVA and KM methods. With separate subset analysis of ypN0i + and ypN1mi patients, there was no significant effect of RNI on OS. This was confirmed with IPTW. CONCLUSIONS: In a national hospital-based study of cN1 invasive breast cancer patients with residual ITC or micrometastases after NAC, RNI did not have a significant effect on OS.
引用
- Kim JK, Karp JM, Gerber NK, et al. Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy. Clin Transl Radiat Oncol. 2022. PMID: 36479237. doi:10.1016/j.ctro.2022.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。